Italian Consensus Conference on Epilepsy and Pregnancy, Labor and Puerperium
暂无分享,去创建一个
E. Perucca | S. Savasta | A. Verrotti | D. Battino | L. Specchio | P. Iannetti | U. Aguglia | L. Pavone | D. Mamoli | D. Pruna | F. Primiero | A. Patella | A. Citernesi | R. Corosu | G. Barboni | G. Battista Cavazzuti | Francesco Maria Guzzetta
[1] W. Hauser,et al. Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes , 2009, Neurology.
[2] C. Harden,et al. Contraception for women with epilepsy. , 2009, Reviews in neurological diseases.
[3] Clinical Excellence,et al. Antenatal care : routine care for the healthy pregnant woman , 2008 .
[4] C. Bearer. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .
[5] T. Tomson,et al. Pharmacokinetics and Therapeutic Drug Monitoring of Newer Antiepileptic Drugs During Pregnancy and the Puerperium , 2007, Clinical pharmacokinetics.
[6] T. Tomson,et al. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives , 2006, Neurology.
[7] J. Menzin,et al. Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage , 2006, Neurology.
[8] E. Perucca,et al. Increased Apparent Oral Clearance of Valproic Acid during Intake of Combined Contraceptive Steroids in Women with Epilepsy , 2006, Epilepsia.
[9] J. Guillebaud,et al. Contraception for Women with Epilepsy , 2006, Epilepsia.
[10] J. Simon,et al. The impact of antiepileptic drug therapy on steroidal contraceptive efficacy , 2006, Epilepsy & Behavior.
[11] H. Leonard,et al. Maternal health in pregnancy and intellectual disability in the offspring: a population-based study. , 2006, Annals of epidemiology.
[12] E. Perucca. British Journal of Clinical Pharmacology Clinically Relevant Drug Interactions with Antiepileptic Drugs , 2022 .
[13] S. Kochen,et al. Seizure control and treatment in pregnancy , 2006, Neurology.
[14] Lamotrigine possibly linked to cleft palate/lip, warns FDA , 2006 .
[15] J. Detoledo. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. , 2006, Neurology.
[16] T. Tomson. Gender Aspects of Pharmacokinetics of New and Old AEDs: Pregnancy and Breast-Feeding , 2005, Therapeutic drug monitoring.
[17] P. Crawford. Best Practice Guidelines for the Management of Women with Epilepsy , 2005, Epilepsia.
[18] B. Irwin,et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[19] R. Kälviäinen,et al. Children exposed to valproate in utero—Population based evaluation of risks and confounding factors for long-term neurocognitive development , 2005, Epilepsy Research.
[20] A. Auvinen,et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring , 2005, Neurology.
[21] M. O’Brien,et al. Management of epilepsy in women , 2005, Postgraduate Medical Journal.
[22] G. Baker,et al. Neuropsychological effects of exposure to anticonvulsant medication in utero , 2005, Neurology.
[23] L. Holmes,et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy , 2005, Neurology.
[24] E. Wooltorton. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss , 2005, Canadian Medical Association Journal.
[25] Í. Lopes-Cendes,et al. Seizure frequency during pregnancy and the puerperium , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[26] Catrin Tudur Smith,et al. Common antiepileptic drugs in pregnancy in women with epilepsy. , 2015, The Cochrane database of systematic reviews.
[27] M. Okada,et al. Physical and Psychomotor Development in the Offspring Born to Mothers with Epilepsy , 2004, Epilepsia.
[28] J. Clayton-Smith,et al. A note on Pierre Marie (1853–1940) , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[29] T. Tomson,et al. Navigating toward Fetal and Maternal Health: The Challenge of Treating Epilepsy in Pregnancy , 2004, Epilepsia.
[30] N. Rasgon. The Relationship Between Polycystic Ovary Syndrome and Antiepileptic Drugs: A Review of the Evidence , 2004, Journal of clinical psychopharmacology.
[31] A. Auvinen,et al. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. , 2004, American journal of epidemiology.
[32] E. Lieberman,et al. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. , 2004, Archives of neurology.
[33] L. Holmes,et al. Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? , 2004, American journal of obstetrics and gynecology.
[34] E. Andermann,et al. Epilepsy and pregnancy: an obstetric perspective. , 2004, American journal of obstetrics and gynecology.
[35] B. Källén,et al. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation‐wide, population‐based register study , 2004, Acta paediatrica.
[36] P. Pennell,et al. The impact of pregnancy and childbirth on the metabolism of lamotrigine , 2004, Neurology.
[37] V. Hiilesmaa,et al. Normal intelligence in children with prenatal exposure to carbamazepine , 2004, Neurology.
[38] M. Dam,et al. Epilepsy and pregnancy: lamotrigine as main drug used , 2004, Acta neurologica Scandinavica.
[39] B. Källén,et al. Anticonvulsant drugs and malformations is there a drug specificity? , 1989, European Journal of Epidemiology.
[40] B. Källén,et al. Anticonvulsant drugs in monotherapy. Effect on the fetus , 1987, European Journal of Epidemiology.
[41] R. Bertollini,et al. Maternal epilepsy and birth defects: A case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC) , 1985, European Journal of Epidemiology.
[42] E. Pschirrer. Seizure disorders in pregnancy. , 2004, Obstetrics and gynecology clinics of North America.
[43] T. Einarson,et al. Malformation Rates in Children of Women with Untreated Epilepsy , 2004, Drug safety.
[44] Julian N. Robinson,et al. Screening for fetal heart disease with ultrasound. , 2003, Clinical obstetrics and gynecology.
[45] D. Petitti. Combination Estrogen–Progestin Oral Contraceptives , 2003 .
[46] T. O'Brien,et al. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months , 2003, Journal of Clinical Neuroscience.
[47] C. Stoll,et al. Prenatal diagnosis of dysmorphic syndromes by routine fetal ultrasound examination across Europe , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[48] A. Richens,et al. Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop , 2003, Epilepsy Research.
[49] C. D'Giano,et al. Major malformations in offspring of women with epilepsy. , 2003, Neurology.
[50] D. Petitti. Clinical practice. Combination estrogen-progestin oral contraceptives. , 2003, The New England journal of medicine.
[51] J. Clayton-Smith,et al. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate , 2002, Seizure.
[52] P. Genton,et al. Epilepsy and women's issues: an update. , 2002, Epileptic disorders : international epilepsy journal with videotape.
[53] T. Nelson,et al. Prenatal evaluation of facial clefts with two-dimensional and adjunctive three-dimensional ultrasonography: a prospective trial. , 2002, American journal of obstetrics and gynecology.
[54] T. Tomson,et al. Psychomotor development in preschool children exposed to antiepileptic drugs in utero , 2002, Acta paediatrica.
[55] J. Little,et al. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth , 2002, Journal of medical genetics.
[56] H. Dolk,et al. Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications , 2002, Journal of medical genetics.
[57] V. Hiilesmaa,et al. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate , 2002, Neurology.
[58] P. Doubilet,et al. Prenatal ultrasonography and the diagnosis of fetal cleft lip. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[59] A. Ornoy,et al. Is carbamazepine teratogenic?: A prospective controlled study of 210 pregnancies , 2001 .
[60] S. Hernández-Díaz,et al. Neural tube defects in relation to use of folic acid antagonists during pregnancy. , 2001, American journal of epidemiology.
[61] D. Battino. Assessment of teratogenic risk , 2001, Epilepsy Research.
[62] D. Chadwick,et al. Additional educational needs in children born to mothers with epilepsy , 2001, Journal of neurology, neurosurgery, and psychiatry.
[63] G. Zampino,et al. Teratogenic Effects of Antiepileptic Drugs: Use of an International Database on Malformations and Drug Exposure (MADRE) , 2000, Epilepsia.
[64] C. Comstock. What to expect from routine midtrimester screening for congenital heart disease. , 2000, Seminars in perinatology.
[65] D. Walshaw,et al. Population based, prospective study of the care of women with epilepsy in pregnancy , 2000, BMJ : British Medical Journal.
[66] M. Dam,et al. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight , 2000, BJOG : an international journal of obstetrics and gynaecology.
[67] B. Källén,et al. Body Dimensions of Infants Exposed to Antiepileptic Drugs In Utero: Observations Spanning 25 Years , 2000, Epilepsia.
[68] L. Pedersen,et al. Birth outcomes in women exposed to anticonvulsant drugs , 2000, Acta neurologica Scandinavica.
[69] I. Arroyo,et al. Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study. , 2000, American journal of medical genetics.
[70] T. Tomson,et al. Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population‐based study , 2000, Developmental medicine and child neurology.
[71] G. Baker,et al. The Stigma of Epilepsy: A European Perspective , 2000, Epilepsia.
[72] A. Hofman,et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring , 1999, Annals of neurology.
[73] U. Lehmkuhl,et al. Long‐Term Neuropsychological Consequences of Maternal Epilepsy and Anticonvulsant Treatment During Pregnancy for School‐Age Children and Adolescents , 1999, Epilepsia.
[74] G. Avanzini,et al. Malformations in Offspring of Women with Epilepsy: A Prospective Study , 1999, Epilepsia.
[75] G. Avanzini,et al. Intrauterine growth in the offspring of epileptic women: a prospective multicenter study , 1999, Epilepsy Research.
[76] G. Avanzini,et al. Congenital malformations due to antiepileptic drugs , 1999, Epilepsy Research.
[77] K. Nicolaides,et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study , 1999, BMJ.
[78] U. Lehmkuhl,et al. Epilepsy and Neuropsychological Consequences of Maternal Anticonvulsant Treatment During Pregnancy for School-Age Children and Adolescents , 1999 .
[79] Practice Parameter: Management Issues for Women with Epilepsy (Summary Statement) , 1998, Epilepsia.
[80] M. Dam,et al. Pregnancy and Epilepsy: A Retrospective Study of 151 Pregnancies , 1998 .
[81] W. Hauser,et al. Pregnancies of Women with Epilepsy: A Population‐Based Study in Iceland , 1998, Epilepsia.
[82] C. Zahn. Neurologic Care of Pregnant Women with Epilepsy , 1998, Epilepsia.
[83] S. Tanaka,et al. Heterogeneity of Ictal SPECT Findings in Nine Cases of West Syndrome , 1998, Epilepsia.
[84] S. Broman,et al. Maternal and neonatal risk factors for mental retardation: defining the 'at-risk' child. , 1998, Early human development.
[85] A. Hofman,et al. Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy , 1997, Epilepsia.
[86] S. Jick,et al. Anticonvulsants and Congenital Malformations , 1997, Pharmacotherapy.
[87] A. Ornoy,et al. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. , 1996, Archives of disease in childhood.
[88] D. Rubin,et al. In utero exposure to phenobarbital and intelligence deficits in adult men. , 1995, JAMA.
[89] G. Koren,et al. Effects of maternal epilepsy on children's neurodevelopment , 1995 .
[90] A. Dessens,et al. Studies on long‐lasting consequences of prenatal exposure to anticonvulsant drugs , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[91] H. Steinhausen,et al. The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors , 1994, Acta paediatrica.
[92] H. Steinhausen,et al. The psychological development of children of epileptic parents. I. Study design and comparative findings , 1994, Acta paediatrica.
[93] G. Borm,et al. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: A multi-centre prospective study , 1994, Epilepsy Research.
[94] R. Weksberg,et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. , 1994, JAMA.
[95] C. Waters,et al. Outcomes of pregnancy associated with antiepileptic drugs. , 1994, Archives of neurology.
[96] T. Tomson,et al. Epilepsy and Pregnancy: A Prospective Study of Seizure Control in Relation to Free and Total Plasma Concentrations of Carbamazepine and Phenytoin , 1994, Epilepsia.
[97] Vidović Mi,et al. Trimestral changes of seizure frequency in pregnant epileptic women. , 1994 .
[98] M. Vidović,et al. Trimestral changes of seizure frequency in pregnant epileptic women. , 1994, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[99] M. Khoury,et al. The contribution of maternal epilepsy and its treatment to the etiology of oral clefts: A population based case‐control study , 1994, Genetic epidemiology.
[100] V. Myllylä,et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. , 1994, The New England journal of medicine.
[101] Z. Blumenfeld,et al. The early diagnosis of neural tube defects , 1993, Prenatal diagnosis.
[102] J. Hopper,et al. The effect of pregnancy on the epilepsies: a study of 37 pregnancies. , 1993, Australian and New Zealand journal of medicine.
[103] F. Andermann,et al. Improved pregnancy outcome in epileptic women in the last decade: Relationship to maternal anticonvulsant therapy , 1992, Brain and Development.
[104] L. Holmes,et al. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. , 1992, Neurotoxicology and teratology.
[105] S. Aslan,et al. Antiepileptic therapy and teratogenicity in Turkey. , 1992, International journal of clinical pharmacology, therapy, and toxicology.
[106] C. J. Sells,et al. Epilepsy in pregnancy: developmental outcome of offspring at 12 months. , 1992, Neurology.
[107] D. Grobbee,et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. , 1992, Neurology.
[108] G. Regesta,et al. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. , 1992, Neurology.
[109] M. Yerby,et al. Antiepileptic drug disposition during pregnancy. , 1992, Neurology.
[110] D. Rating,et al. Major and minor birth malformations and antiepileptic drugs. , 1992, Neurology.
[111] G. Trentin,et al. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. , 1992, Neurology.
[112] A. Delgado-Escueta,et al. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. , 1992, Neurology.
[113] K. Otani,et al. Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. , 1992, Neurology.
[114] H. Nau,et al. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. , 1992, Neurology.
[115] R. Loewenson,et al. Antiepileptics and the development of congenital anomalies. , 1992, Neurology.
[116] M. Schertzer,et al. A polymorphic complex dinucleotide repeat at the telomeric D8S7 locus. , 1992, Human heredity.
[117] M. Hadders‐Algra,et al. Antiepileptic medication in pregnancy: Late effects on the children's central nervous system development , 1991, American journal of obstetrics and gynecology.
[118] M. Yerby. Pregnancy and Epilepsy , 1991, Epilepsia.
[119] B. Abdulwahab,et al. Congenital malformations before and after the onset of maternal epilepsy , 1991, Acta neurologica Scandinavica.
[120] M. Eadie,et al. Plasma Antiepileptic Drug Concentrations During Pregnancy , 1991, Epilepsia.
[121] F. Rosa,et al. Spina bifida in infants of women treated with carbamazepine during pregnancy. , 1991, The New England journal of medicine.
[122] G. Mawer,et al. Fetal phenytoin exposure, hypoplastic nails, and jitteriness. , 1991, Archives of disease in childhood.
[123] N. Hotham,et al. Epilepsy and Pregnancy ‐ A Review of 98 Pregnancies , 1990, The Australian & New Zealand journal of obstetrics & gynaecology.
[124] M. Eadie,et al. Antiepileptic drug intake during pregnancy and malformed offspring , 1990, Epilepsy Research.
[125] E. Gaily,et al. SPECIFIC COGNITIVE DYSFUNCTION IN CHILDREN WITH EPILEPTIC MOTHERS , 1990, Developmental medicine and child neurology.
[126] C. J. Sells,et al. Pharmacokinetics of anticonvulsants in pregnancy: Alterations in plasma protein binding , 1990, Epilepsy Research.
[127] James W. P. Campbell,et al. Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida. , 1990, American journal of obstetrics and gynecology.
[128] E. Gaily,et al. A transient retardation of early postnatal growth in drug-exposed children of epileptic mothers , 1989, Epilepsy Research.
[129] K. Jones,et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. , 1989, The New England journal of medicine.
[130] I. O. Gjerde,et al. The course of epilepsy during pregnancy: a study of 78 cases. , 1989, Acta neurologica Scandinavica.
[131] E. Gaily,et al. Intelligence of children of epileptic mothers. , 1988, The Journal of pediatrics.
[132] M. Goto,et al. Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk Factors , 1988, Epilepsia.
[133] A. Bardy. Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study , 1987, Acta neurologica Scandinavica.
[134] E. Perucca. Drug metabolism in pregnancy, infancy and childhood. , 1987, Pharmacology & therapeutics.
[135] D. Lindhout,et al. IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTS , 1986, The Lancet.
[136] H. Nau,et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. , 1986, The Journal of pediatrics.
[137] B. Källén,et al. A register study of maternal epilepsy and delivery outcome with special reference to drug use , 1986, Acta neurologica Scandinavica.
[138] Sheryl M. Davies. Epilepsy and pregnancy. , 1927, American family physician.
[139] J. Opitz,et al. Teratogenicity of anticonvulsant drugs. , 1985, American journal of medical genetics.
[140] M. Friis,et al. Congenital heart defects in live-born children of epileptic parents. , 1985, Archives of neurology.
[141] K. Otani. Risk Factors for the Increased Seizure Frequency during Pregnancy and Puerperium , 1985, Folia psychiatrica et neurologica japonica.
[142] S. Kaneko,et al. 100. The Physical and Mental Development of Infants Born to Mothers Treated with Antiepileptic Drugs , 1984 .
[143] F. Dreifuss,et al. Teratogenicity of anticonvulsant drugs. II: A prospective study. , 1984, American journal of medical genetics.
[144] T. Kelly,et al. Teratogenicity of anticonvulsant drugs. IV: The association of clefting and epilepsy. , 1984, American journal of medical genetics.
[145] Wells Wt. Definition of insanity. , 1984 .
[146] D. Lindhout,et al. SPINA BIFIDA AND IN-UTERO EXPOSURE TO VALPROATE , 1984, The Lancet.
[147] D. Lindhout,et al. Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine) , 1984, Epilepsia.
[148] R. Guzmán Toledano,et al. [Epilepsy, anticonvulsants and pregnancy]. , 1984, Ginecologia y obstetricia de Mexico.
[149] D. Rating,et al. [Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development]. , 2008, Deutsche medizinische Wochenschrift.
[150] D. Chadwick. Pharmacokinetics of anticonvulsants. , 1983, British journal of hospital medicine.
[151] G. Avanzini,et al. Change of seizure frequency in pregnant epileptic women. , 1983, Journal of neurology, neurosurgery, and psychiatry.
[152] J. Ellenberg,et al. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children , 1982, Neurology.
[153] E. Robert,et al. MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS , 1982, The Lancet.
[154] E. Perucca,et al. Plasma Protein Binding of Drugs in Pregnancy , 1982, Clinical pharmacokinetics.
[155] G. Avanzini,et al. Modifications of seizure frequency in pregnant patients with epilepsy a prospective study , 1982 .
[156] V. Hiilesmaa,et al. FETAL HEAD GROWTH RETARDATION ASSOCIATED WITH MATERNAL ANTIEPILEPTIC DRUGS , 1981, The Lancet.
[157] F. Majewski,et al. The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. , 1981, International journal of biological research in pregnancy.
[158] K. Inanaga,et al. Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan , 1980, Epilepsia.
[159] R. Purcell,et al. EPIDEMIC AND ENDEMIC HEPATITIS IN INDIA: EVIDENCE FOR A NON-A, NON-B HEPATITIS VIRUS ÆTIOLOGY , 1980, The Lancet.
[160] M. Friis. Epilepsy Among Parents of Children with Facial Clefts , 1979, Epilepsia.
[161] M. Granström. Development of the Children of Epileptic Mothers , 1979 .
[162] V. Hiilesmaa,et al. Fetal heart rate during a maternal grand mal epileptic seizure , 1979, Journal of perinatal medicine.
[163] W. Hauser,et al. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. , 1978, International journal of epidemiology.
[164] F. Martín. [Pregnancy and epilepsy]. , 1978, Revue medicale de la Suisse romande.
[165] A. Adelstein,et al. Maternal drug histories and congenital abnormalities. , 1977, British medical journal.
[166] M. Wéber,et al. [Epilepsy, anticonvulsants and pregnancy]. , 1977, Archives francaises de pediatrie.
[167] David W. Smith,et al. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. , 1976, The Journal of pediatrics.
[168] Alasdair Breckenridge,et al. Meyler's Side Effects of Drugs , 1976 .
[169] G. Proud,et al. ANAPHYLACTIC REACTION TO APROTININ , 1976, The Lancet.
[170] S. Shapiro,et al. Anticonvulsants and parental epilepsy in the development of birth defects. , 1976, Lancet.
[171] A. H. Knight,et al. Epilepsy and Pregnancy: A Study of 153 Pregnancies in 59 Patients , 1975, Epilepsia.
[172] W. Hauser,et al. Do anticonvulsants have a teratogenic effect? , 1974, Archives of neurology.
[173] J. Erickson,et al. Seizure disorder in mothers of children with orofacial clefts: a case-control study. , 1974, The Journal of pediatrics.
[174] H. Meinardi,et al. Are anticonvulsants teratogenic? , 1973, Lancet.
[175] J. Fedrick. Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study , 1973, British medical journal.
[176] J. Meyer. The teratological effects of anticonvulsants and the effects on pregnancy and birth. , 1973, European neurology.
[177] S. Meadow,et al. Maternal epilepsy and abnormalities of the fetus and newborn. , 1972, Lancet.
[178] J. Elshove,et al. [Congenital abnormalities, cleft lip and cleft palate in particular, in children of epileptic mothers]. , 1971, Nederlands tijdschrift voor geneeskunde.
[179] K. Dronamraju. Epilepsy and cleft lip and palate. , 1970, Lancet.
[180] Broadhurst Ad. L-tryptophan verses E.C.T. , 1970 .
[181] A. Webb,et al. Torulopsis glabrata septicaemia treated with 5-fluorocytosine. , 1970, Lancet.
[182] S. Meadow,et al. Congenital Abnormalities and Anticonvulsant Drugs , 1970, Proceedings of the Royal Society of Medicine.
[183] Saunders Kb. END--OR BEGINNING? , 1965 .
[184] W. Jb. Government service and freedom. , 1947 .